Details

Autor(en) / Beteiligte

• Pęczkowska, Mariola
• Kowalska, Aldona
• Sygut, Jacek
• Waligórski, Dariusz
• Malinoc, Angelica
• Janaszek-Sitkowska, Hanna
• Prejbisz, Aleksander
• Januszewicz, Andrzej
• Neumann, Hartmut P. H.

Titel

Testing new susceptibility genes in the cohort of apparently sporadic phaeochromocytoma/paraganglioma patients with clinical characteristics of hereditary syndromes

Ist Teil von

• Clinical endocrinology (Oxford), 2013-12, Vol.79 (6), p.817-823

Ort / Verlag

Oxford: Blackwell Publishing Ltd

Erscheinungsjahr

2013

Quelle

Access via Wiley Online Library

Beschreibungen/Notizen

• Background Phaeochromocytoma (PCC) and paraganglioma (PGL) can occur sporadically or as a part of familial cancer syndromes. Red flags of hereditary syndromes are young age and multifocal tumours. We hypothesized that such patients are candidates for further molecular diagnosis in case of normal results in ‘classical’ genes. Material and methods We selected patients with PCC/PGL under the age of 40 and/or with multiple tumours. First, we tested the genes RET, VHL, NF1, SDHB, SDHC and SDHD. Patients without mutations in these genes were tested for mutations in MAX, TMEM127 and SDHAF2. Results In 153 patients included, mutations were detected in the classical genes in 72 patients (47%) [RET‐22 (14%), VHL‐13 (9%), NF1‐3 (2%), SDHB‐13 (9%), SDHC‐3 (2%), SDHD‐16 (11%), SDHB large deletions– 2 (1%)]. One patient with MAXc.223C>T (p.R75X) mutation was detected. It was a male with bilateral, metachronous phaeochromocytomas diagnosed in 36 and 40 years of age. Remarkably, he showed in the period before the MAX gene was detected, a RET p. Y791F variant. During 10‐year follow‐up, we did not find any thyroid abnormalities. LOH examination of tumour tissue showed somatic loss of the wild‐type allele of MAX. Conclusion Analysis of the MAX gene should be performed in selected patients, especially those with bilateral adrenal phaeochromocytoma in whom mutations of the classical genes are absent. Our study provides with further support that Y791F RET is a polymorphism.